New Enhancing CLIA Act: What Lab Directors Need to Know
The proposal seeks to move any future LDT authority away from the FDA
Already a member? Log in here
Essential
Subscribe today for access to
Articles and Reports
How to Stay Ahead of Anticipated CLIA Deficiencies
Consultant Nora Hess offers suggestions for clinical labs to navigate these problems
Already a member? Log in here
FDA Watch: Natera, Valar Labs Receive FDA Clearances for Bladder Cancer Tests
Natera’s assay focuses on the need for adjuvant therapy, while Valar’s test stratifies risk of recurrence
Already a member? Log in here
News-At-A-Glance: Latest CCI Edits Update
...
Already a member? Log in here
News-At-A-Glance: Noridian Redetermination Request Update
...
Already a member? Log in here
News-At-A-Glance: Another Physician Admits Accepting Bribes From BLS
...
Already a member? Log in here
Compliance Corner
...
Already a member? Log in here
OIG Joins Medicaid Whistleblower Kickback Lawsuit Involving Tenet Healthcare
...
Already a member? Log in here
Ameritox vs. Millennium Laboratories Court Saga Continues
...
Already a member? Log in here
Eleventh-Hour Settlement Avoids Trial for Hospital Fraud Case
...
Already a member? Log in here
Government Health Care Budgets Include Increased Funding to Fight Fraud
...
Already a member? Log in here